An Open Label Pilot Study of Photo-Biomodulation Therapy.

Not Applicable

Recruiting

• Conditions: Cognitive impairment; Neurological - Studies of the normal brain and nervous system

• Registration Number: ACTRN12623001040651
• Lead Sponsor: The University of the Sunshine Coast

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-09-26
• Last Update Posted: 23 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Persons aged 50-70 years.
- Participants must be able to understand Research Project Information Sheet (RPIS) and provide written informed consent on the Participant Informed Consent Form (PICF).
- Participants must be able to undergo MRI, undertake neuropsychological and EEG assessments, and tolerate the PMBT therapy.

Exclusion Criteria

- Diagnosed dementia and mild cognitive impairment
- Significant psychiatric history including psychosis, bipolar disorder, major depressive disorder including suicidality.
- Any unstable medical (e.g., severe/uncontrolled hypertension) or neurological condition (e.g., Parkinson’s Disease)
- Severe cardiovascular disease, history of stroke, recent myocardial infarction
- Any contraindication to MRI or PBMT therapy
- Development of serious, adverse, or unexpected events/reactions during the trial
- Previous reaction to PBMT therapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified